NDC 55289-920-98
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-98
- Package NDCs from labels
- 55289-920-98
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Acetaminophen | ACETAMINOPHEN | PD-Rx Pharmaceuticals, Inc. | 3f96aeb1-a533-4d36-9a1f-62fc094b6754 | 2025-10-08 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | e466d963-469a-4b1c-87f9-2e3e1e9bdf3d | 2025-10-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 2d01e583-670a-46f4-b5f2-3fad46d0376f | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | 4cdd7ac5-a52c-4766-afeb-1b5e567a328c | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | aea4e2a1-2089-40dc-9eee-deaab4f21397 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | b85bdc1f-1ffb-40d5-a407-e8de2891996d | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | PD-Rx Pharmaceuticals, Inc. | 6a541749-5d14-44aa-a409-5e51f5bbf929 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Cefdinir | CEFDINIR | PD-Rx Pharmaceuticals, Inc. | 463084e5-908d-4bbc-b542-10b98211e28e | 2025-10-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | cc15ef60-6956-4d34-b86d-72cdd0c0c0bb | 2025-10-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| ESZOPICLONE | ESZOPICLONE | PD-Rx Pharmaceuticals, Inc. | bb972d36-4b2c-45ae-8504-3a16d352dd8b | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Cefdinir | CEFDINIR | PD-Rx Pharmaceuticals, Inc. | 3c2130f9-a0d8-4a4e-bcad-36379202b7bb | 2025-10-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Moxifloxacin Hydrochloride Tablets, 400 mg | MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG | PD-Rx Pharmaceuticals, Inc. | 5c2a9116-d6e4-429e-88bb-bb6bfedac2f0 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Levofloxacin | LEVOFLOXACIN | PD-Rx Pharmaceuticals, Inc. | b8defac4-9deb-433b-928e-0ef4ee0123a2 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | PD-Rx Pharmaceuticals, Inc. | 46eeb12f-7e38-4828-b7d1-26b6155bc64a | 2025-10-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | PD-Rx Pharmaceuticals, Inc. | b422c5eb-9a6d-4f8c-863d-ca515ec780c2 | 2025-10-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 91b4c802-9c6b-49bb-b5a7-661e1917ef34 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | PD-Rx Pharmaceuticals, Inc. | e959b07b-3e6c-44cc-9a6d-c6689d393e4c | 2025-10-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| SILODOSIN | SILODOSIN | PD-Rx Pharmaceuticals, Inc. | 365a86b3-748a-465d-b489-dba1479be670 | 2025-10-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| LISINOPRIL | LISINOPRIL | PD-Rx Pharmaceuticals, Inc. | 705582ed-da8c-418f-8bb2-fc0b74ed0a88 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.